5-methoxy-6-methyl-2-aminoindan has been researched along with 4-iodo-2,5-dimethoxyphenylisopropylamine in 3 studies
| Studies (5-methoxy-6-methyl-2-aminoindan) | Trials (5-methoxy-6-methyl-2-aminoindan) | Recent Studies (post-2010) (5-methoxy-6-methyl-2-aminoindan) | Studies (4-iodo-2,5-dimethoxyphenylisopropylamine) | Trials (4-iodo-2,5-dimethoxyphenylisopropylamine) | Recent Studies (post-2010) (4-iodo-2,5-dimethoxyphenylisopropylamine) |
|---|---|---|---|---|---|
| 13 | 0 | 0 | 843 | 1 | 127 |
| Protein | Taxonomy | 5-methoxy-6-methyl-2-aminoindan (IC50) | 4-iodo-2,5-dimethoxyphenylisopropylamine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0032 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurrasch, D; Marona-Lewicka, D; Nichols, DE; Parker, MA; Shulgin, AT | 1 |
| Huang, X; Nichols, DE | 1 |
| Marona-Lewicka, D; Nichols, DE; Thisted, RA | 1 |
3 other study(ies) available for 5-methoxy-6-methyl-2-aminoindan and 4-iodo-2,5-dimethoxyphenylisopropylamine
| Article | Year |
|---|---|
Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA).
Topics: 3,4-Methylenedioxyamphetamine; Animals; Antidepressive Agents; Behavior, Animal; Brain; Dioxoles; In Vitro Techniques; Male; Rats; Rats, Sprague-Dawley; Serotonin Agents; Synaptosomes | 1998 |
5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Hippocampus; Hydrazines; Indans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1993 |
Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
Topics: Amphetamine; Amphetamines; Animals; Apomorphine; Behavior, Animal; Cues; Discrimination Learning; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluorobenzenes; Hallucinogens; Haloperidol; Indans; Injections, Intraperitoneal; Lysergic Acid Diethylamide; Male; Piperidines; Psychotic Disorders; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors | 2005 |